Clinical Trial Update: ORBERA365 Post-Marketing Clinical Follow-up Study

View source ↗

Summary

The ORBERA365 post-marketing clinical follow-up study has been terminated. It tracked obesity/overweight outcomes in patients using the ORBERA365 gastric balloo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• ORBERA365

Snippet

Sponsor: Apollo Endosurgery, Inc. | Conditions: Obesity, Overweight | Status: TERMINATED